nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—CA1—esophageal cancer	0.235	0.433	CbGaD
Furosemide—CA2—esophageal cancer	0.178	0.329	CbGaD
Furosemide—ABCC2—esophageal cancer	0.129	0.238	CbGaD
Furosemide—PGD—Methotrexate—esophageal cancer	0.118	0.416	CbGbCtD
Furosemide—SLC22A11—Methotrexate—esophageal cancer	0.0351	0.123	CbGbCtD
Furosemide—ABCC2—Carboplatin—esophageal cancer	0.035	0.123	CbGbCtD
Furosemide—ABCC2—Cisplatin—esophageal cancer	0.0299	0.105	CbGbCtD
Furosemide—SLC22A8—Methotrexate—esophageal cancer	0.0204	0.0717	CbGbCtD
Furosemide—ABCC2—Methotrexate—esophageal cancer	0.0194	0.0683	CbGbCtD
Furosemide—SLC22A6—Methotrexate—esophageal cancer	0.0142	0.05	CbGbCtD
Furosemide—ALB—Methotrexate—esophageal cancer	0.0121	0.0425	CbGbCtD
Furosemide—CA6—exocrine gland—esophageal cancer	0.00293	0.0961	CbGeAlD
Furosemide—Ototoxicity—Cisplatin—esophageal cancer	0.00225	0.0479	CcSEcCtD
Furosemide—Hydronephrosis—Capecitabine—esophageal cancer	0.00174	0.037	CcSEcCtD
Furosemide—Glucose tolerance impaired—Cisplatin—esophageal cancer	0.00168	0.0357	CcSEcCtD
Furosemide—Indapamide—CA2—esophageal cancer	0.00152	0.784	CrCbGaD
Furosemide—Diuresis—Cisplatin—esophageal cancer	0.00146	0.031	CcSEcCtD
Furosemide—Tetany—Cisplatin—esophageal cancer	0.00138	0.0295	CcSEcCtD
Furosemide—SLCO2A1—neck—esophageal cancer	0.00133	0.0438	CbGeAlD
Furosemide—Hepatic cirrhosis—Methotrexate—esophageal cancer	0.00129	0.0275	CcSEcCtD
Furosemide—PGD—neck—esophageal cancer	0.00119	0.039	CbGeAlD
Furosemide—CA7—trachea—esophageal cancer	0.00116	0.0382	CbGeAlD
Furosemide—CA2—exocrine gland—esophageal cancer	0.00101	0.0331	CbGeAlD
Furosemide—CA7—digestive system—esophageal cancer	0.001	0.0328	CbGeAlD
Furosemide—SLC12A1—epithelium—esophageal cancer	0.000984	0.0323	CbGeAlD
Furosemide—SLCO2A1—epithelium—esophageal cancer	0.000908	0.0298	CbGeAlD
Furosemide—SLCO2A1—bronchus—esophageal cancer	0.000895	0.0293	CbGeAlD
Furosemide—CA9—digestive system—esophageal cancer	0.000879	0.0288	CbGeAlD
Furosemide—SLCO2A1—trachea—esophageal cancer	0.000803	0.0263	CbGeAlD
Furosemide—PGD—bronchus—esophageal cancer	0.000797	0.0261	CbGeAlD
Furosemide—PGD—smooth muscle tissue—esophageal cancer	0.00078	0.0256	CbGeAlD
Furosemide—CA4—neck—esophageal cancer	0.000778	0.0255	CbGeAlD
Furosemide—SLC22A11—digestive system—esophageal cancer	0.00077	0.0253	CbGeAlD
Furosemide—CA12—trachea—esophageal cancer	0.000756	0.0248	CbGeAlD
Furosemide—PGD—trachea—esophageal cancer	0.000716	0.0235	CbGeAlD
Furosemide—CA12—digestive system—esophageal cancer	0.00065	0.0213	CbGeAlD
Furosemide—CA2—neck—esophageal cancer	0.000645	0.0212	CbGeAlD
Furosemide—PGD—digestive system—esophageal cancer	0.000616	0.0202	CbGeAlD
Furosemide—SLCO2A1—lung—esophageal cancer	0.000577	0.0189	CbGeAlD
Furosemide—CA12—lung—esophageal cancer	0.000543	0.0178	CbGeAlD
Furosemide—Hypomagnesaemia—Capecitabine—esophageal cancer	0.000524	0.0112	CcSEcCtD
Furosemide—CA1—digestive system—esophageal cancer	0.000515	0.0169	CbGeAlD
Furosemide—PGD—lung—esophageal cancer	0.000514	0.0169	CbGeAlD
Furosemide—Blood triglycerides increased—Capecitabine—esophageal cancer	0.000508	0.0108	CcSEcCtD
Furosemide—CA5B—lung—esophageal cancer	0.000487	0.016	CbGeAlD
Furosemide—Hyperuricaemia—Cisplatin—esophageal cancer	0.000487	0.0104	CcSEcCtD
Furosemide—Hearing impaired—Cisplatin—esophageal cancer	0.000474	0.0101	CcSEcCtD
Furosemide—Thrombosis—Capecitabine—esophageal cancer	0.00047	0.01	CcSEcCtD
Furosemide—Pain—Carboplatin—esophageal cancer	0.000469	0.01	CcSEcCtD
Furosemide—CA4—trachea—esophageal cancer	0.000468	0.0153	CbGeAlD
Furosemide—Blister—Capecitabine—esophageal cancer	0.000462	0.00983	CcSEcCtD
Furosemide—Blood uric acid increased—Cisplatin—esophageal cancer	0.00046	0.00979	CcSEcCtD
Furosemide—CA2—epithelium—esophageal cancer	0.000439	0.0144	CbGeAlD
Furosemide—Body temperature increased—Carboplatin—esophageal cancer	0.000434	0.00925	CcSEcCtD
Furosemide—CA2—bronchus—esophageal cancer	0.000432	0.0142	CbGeAlD
Furosemide—CA1—lung—esophageal cancer	0.00043	0.0141	CbGeAlD
Furosemide—SLC22A5—bronchus—esophageal cancer	0.000425	0.0139	CbGeAlD
Furosemide—ABCC2—digestive system—esophageal cancer	0.000424	0.0139	CbGeAlD
Furosemide—CA2—smooth muscle tissue—esophageal cancer	0.000423	0.0139	CbGeAlD
Furosemide—Bumetanide—PTGS2—esophageal cancer	0.000419	0.216	CrCbGaD
Furosemide—Injection site pain—Capecitabine—esophageal cancer	0.000408	0.00868	CcSEcCtD
Furosemide—CA4—digestive system—esophageal cancer	0.000403	0.0132	CbGeAlD
Furosemide—Eruption—Methotrexate—esophageal cancer	0.000403	0.00858	CcSEcCtD
Furosemide—SLCO2A1—lymph node—esophageal cancer	0.000395	0.0129	CbGeAlD
Furosemide—CA2—trachea—esophageal cancer	0.000388	0.0127	CbGeAlD
Furosemide—SLC22A5—trachea—esophageal cancer	0.000382	0.0125	CbGeAlD
Furosemide—Polyuria—Cisplatin—esophageal cancer	0.000373	0.00795	CcSEcCtD
Furosemide—Deafness—Cisplatin—esophageal cancer	0.000366	0.0078	CcSEcCtD
Furosemide—Hypocalcaemia—Capecitabine—esophageal cancer	0.000363	0.00774	CcSEcCtD
Furosemide—Haemolytic anaemia—Cisplatin—esophageal cancer	0.000363	0.00773	CcSEcCtD
Furosemide—PGD—lymph node—esophageal cancer	0.000352	0.0115	CbGeAlD
Furosemide—Hearing impaired—Capecitabine—esophageal cancer	0.00035	0.00745	CcSEcCtD
Furosemide—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.000339	0.00721	CcSEcCtD
Furosemide—CA4—lung—esophageal cancer	0.000336	0.011	CbGeAlD
Furosemide—CA2—digestive system—esophageal cancer	0.000334	0.011	CbGeAlD
Furosemide—CA5B—lymph node—esophageal cancer	0.000333	0.0109	CbGeAlD
Furosemide—Hyponatraemia—Cisplatin—esophageal cancer	0.000329	0.00701	CcSEcCtD
Furosemide—SLC22A5—digestive system—esophageal cancer	0.000329	0.0108	CbGeAlD
Furosemide—Irritability—Cisplatin—esophageal cancer	0.000313	0.00666	CcSEcCtD
Furosemide—Blood creatinine increased—Cisplatin—esophageal cancer	0.000307	0.00654	CcSEcCtD
Furosemide—Dehydration—Cisplatin—esophageal cancer	0.000305	0.00649	CcSEcCtD
Furosemide—Urine output increased—Capecitabine—esophageal cancer	0.000301	0.00641	CcSEcCtD
Furosemide—Orthostatic hypotension—Cisplatin—esophageal cancer	0.000299	0.00638	CcSEcCtD
Furosemide—Hypokalaemia—Cisplatin—esophageal cancer	0.000298	0.00635	CcSEcCtD
Furosemide—Cramp muscle—Cisplatin—esophageal cancer	0.000295	0.00629	CcSEcCtD
Furosemide—CA1—lymph node—esophageal cancer	0.000294	0.00965	CbGeAlD
Furosemide—Mental disability—Capecitabine—esophageal cancer	0.000289	0.00615	CcSEcCtD
Furosemide—Thrombophlebitis—Capecitabine—esophageal cancer	0.000279	0.00594	CcSEcCtD
Furosemide—CA2—lung—esophageal cancer	0.000279	0.00915	CbGeAlD
Furosemide—Diabetes mellitus—Capecitabine—esophageal cancer	0.000278	0.00592	CcSEcCtD
Furosemide—Pancreatitis—Cisplatin—esophageal cancer	0.000278	0.00591	CcSEcCtD
Furosemide—Polyuria—Capecitabine—esophageal cancer	0.000275	0.00586	CcSEcCtD
Furosemide—Photosensitivity—Capecitabine—esophageal cancer	0.000275	0.00586	CcSEcCtD
Furosemide—SLC22A5—lung—esophageal cancer	0.000274	0.009	CbGeAlD
Furosemide—Swelling—Capecitabine—esophageal cancer	0.000274	0.00583	CcSEcCtD
Furosemide—Deafness—Capecitabine—esophageal cancer	0.00027	0.00575	CcSEcCtD
Furosemide—Vascular purpura—Capecitabine—esophageal cancer	0.00027	0.00575	CcSEcCtD
Furosemide—Haemolytic anaemia—Capecitabine—esophageal cancer	0.000268	0.0057	CcSEcCtD
Furosemide—Hyperuricaemia—Methotrexate—esophageal cancer	0.000267	0.00569	CcSEcCtD
Furosemide—ALB—lymph node—esophageal cancer	0.000259	0.00848	CbGeAlD
Furosemide—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.000256	0.00545	CcSEcCtD
Furosemide—Thirst—Capecitabine—esophageal cancer	0.000254	0.00541	CcSEcCtD
Furosemide—Vasculitis—Methotrexate—esophageal cancer	0.000254	0.00541	CcSEcCtD
Furosemide—Dermatitis bullous—Capecitabine—esophageal cancer	0.000253	0.00538	CcSEcCtD
Furosemide—Blood uric acid increased—Methotrexate—esophageal cancer	0.000252	0.00537	CcSEcCtD
Furosemide—Purpura—Capecitabine—esophageal cancer	0.000251	0.00534	CcSEcCtD
Furosemide—Renal failure—Cisplatin—esophageal cancer	0.000248	0.00529	CcSEcCtD
Furosemide—Lethargy—Capecitabine—esophageal cancer	0.000246	0.00525	CcSEcCtD
Furosemide—Hyponatraemia—Capecitabine—esophageal cancer	0.000243	0.00517	CcSEcCtD
Furosemide—ABCC2—lymph node—esophageal cancer	0.000242	0.00794	CbGeAlD
Furosemide—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000239	0.00509	CcSEcCtD
Furosemide—Aplastic anaemia—Methotrexate—esophageal cancer	0.000233	0.00495	CcSEcCtD
Furosemide—Irritability—Capecitabine—esophageal cancer	0.000231	0.00491	CcSEcCtD
Furosemide—CA4—lymph node—esophageal cancer	0.00023	0.00754	CbGeAlD
Furosemide—Urinary retention—Capecitabine—esophageal cancer	0.00023	0.00489	CcSEcCtD
Furosemide—Blood creatinine increased—Capecitabine—esophageal cancer	0.000226	0.00482	CcSEcCtD
Furosemide—Dehydration—Capecitabine—esophageal cancer	0.000225	0.00478	CcSEcCtD
Furosemide—Bladder pain—Methotrexate—esophageal cancer	0.000224	0.00477	CcSEcCtD
Furosemide—Urine output increased—Methotrexate—esophageal cancer	0.000224	0.00477	CcSEcCtD
Furosemide—Urinary tract disorder—Cisplatin—esophageal cancer	0.000224	0.00477	CcSEcCtD
Furosemide—Urethral disorder—Cisplatin—esophageal cancer	0.000222	0.00473	CcSEcCtD
Furosemide—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000221	0.0047	CcSEcCtD
Furosemide—Hypokalaemia—Capecitabine—esophageal cancer	0.00022	0.00468	CcSEcCtD
Furosemide—Visual impairment—Cisplatin—esophageal cancer	0.000218	0.00465	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000217	0.00463	CcSEcCtD
Furosemide—Muscular weakness—Capecitabine—esophageal cancer	0.000213	0.00454	CcSEcCtD
Furosemide—Eye disorder—Cisplatin—esophageal cancer	0.000212	0.00451	CcSEcCtD
Furosemide—Tinnitus—Cisplatin—esophageal cancer	0.000211	0.0045	CcSEcCtD
Furosemide—Abdominal distension—Capecitabine—esophageal cancer	0.00021	0.00448	CcSEcCtD
Furosemide—Thrombophlebitis—Methotrexate—esophageal cancer	0.000208	0.00442	CcSEcCtD
Furosemide—Diabetes mellitus—Methotrexate—esophageal cancer	0.000207	0.0044	CcSEcCtD
Furosemide—Photosensitivity—Methotrexate—esophageal cancer	0.000205	0.00436	CcSEcCtD
Furosemide—Polyuria—Methotrexate—esophageal cancer	0.000205	0.00436	CcSEcCtD
Furosemide—Immune system disorder—Cisplatin—esophageal cancer	0.000205	0.00436	CcSEcCtD
Furosemide—Arrhythmia—Cisplatin—esophageal cancer	0.000202	0.00431	CcSEcCtD
Furosemide—Malnutrition—Cisplatin—esophageal cancer	0.000197	0.0042	CcSEcCtD
Furosemide—Erythema—Cisplatin—esophageal cancer	0.000197	0.0042	CcSEcCtD
Furosemide—Flatulence—Cisplatin—esophageal cancer	0.000194	0.00414	CcSEcCtD
Furosemide—CA2—lymph node—esophageal cancer	0.000191	0.00625	CbGeAlD
Furosemide—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000191	0.00406	CcSEcCtD
Furosemide—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000191	0.00406	CcSEcCtD
Furosemide—Muscle spasms—Cisplatin—esophageal cancer	0.00019	0.00404	CcSEcCtD
Furosemide—Hyperglycaemia—Capecitabine—esophageal cancer	0.000188	0.00401	CcSEcCtD
Furosemide—SLC22A5—lymph node—esophageal cancer	0.000188	0.00615	CbGeAlD
Furosemide—Vision blurred—Cisplatin—esophageal cancer	0.000186	0.00396	CcSEcCtD
Furosemide—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000186	0.00396	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000185	0.00393	CcSEcCtD
Furosemide—Lethargy—Methotrexate—esophageal cancer	0.000183	0.00391	CcSEcCtD
Furosemide—Renal failure—Capecitabine—esophageal cancer	0.000183	0.0039	CcSEcCtD
Furosemide—Anaemia—Cisplatin—esophageal cancer	0.000182	0.00389	CcSEcCtD
Furosemide—Leukopenia—Cisplatin—esophageal cancer	0.000177	0.00376	CcSEcCtD
Furosemide—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000176	0.00375	CcSEcCtD
Furosemide—Agranulocytosis—Capecitabine—esophageal cancer	0.000174	0.0037	CcSEcCtD
Furosemide—Irritability—Methotrexate—esophageal cancer	0.000172	0.00366	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000167	0.00355	CcSEcCtD
Furosemide—Urinary tract disorder—Capecitabine—esophageal cancer	0.000165	0.00352	CcSEcCtD
Furosemide—Urethral disorder—Capecitabine—esophageal cancer	0.000164	0.00349	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000162	0.00345	CcSEcCtD
Furosemide—Anaphylactic shock—Cisplatin—esophageal cancer	0.000161	0.00343	CcSEcCtD
Furosemide—Visual impairment—Capecitabine—esophageal cancer	0.000161	0.00343	CcSEcCtD
Furosemide—Erythema multiforme—Capecitabine—esophageal cancer	0.000158	0.00337	CcSEcCtD
Furosemide—Nervous system disorder—Cisplatin—esophageal cancer	0.000158	0.00336	CcSEcCtD
Furosemide—Thrombocytopenia—Cisplatin—esophageal cancer	0.000158	0.00336	CcSEcCtD
Furosemide—Skin disorder—Cisplatin—esophageal cancer	0.000156	0.00333	CcSEcCtD
Furosemide—Eye disorder—Capecitabine—esophageal cancer	0.000156	0.00333	CcSEcCtD
Furosemide—Tinnitus—Capecitabine—esophageal cancer	0.000156	0.00332	CcSEcCtD
Furosemide—Hyperhidrosis—Cisplatin—esophageal cancer	0.000156	0.00332	CcSEcCtD
Furosemide—Eosinophilia—Methotrexate—esophageal cancer	0.000154	0.00328	CcSEcCtD
Furosemide—Anorexia—Cisplatin—esophageal cancer	0.000154	0.00327	CcSEcCtD
Furosemide—Pancreatitis—Methotrexate—esophageal cancer	0.000152	0.00325	CcSEcCtD
Furosemide—Angiopathy—Capecitabine—esophageal cancer	0.000152	0.00323	CcSEcCtD
Furosemide—Immune system disorder—Capecitabine—esophageal cancer	0.000151	0.00322	CcSEcCtD
Furosemide—Hypotension—Cisplatin—esophageal cancer	0.00015	0.00321	CcSEcCtD
Furosemide—Arrhythmia—Capecitabine—esophageal cancer	0.000149	0.00318	CcSEcCtD
Furosemide—Erythema—Capecitabine—esophageal cancer	0.000145	0.0031	CcSEcCtD
Furosemide—Malnutrition—Capecitabine—esophageal cancer	0.000145	0.0031	CcSEcCtD
Furosemide—Paraesthesia—Cisplatin—esophageal cancer	0.000145	0.00308	CcSEcCtD
Furosemide—Flatulence—Capecitabine—esophageal cancer	0.000143	0.00305	CcSEcCtD
Furosemide—Dysgeusia—Capecitabine—esophageal cancer	0.000142	0.00303	CcSEcCtD
Furosemide—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000142	0.00302	CcSEcCtD
Furosemide—Decreased appetite—Cisplatin—esophageal cancer	0.00014	0.00298	CcSEcCtD
Furosemide—Muscle spasms—Capecitabine—esophageal cancer	0.00014	0.00298	CcSEcCtD
Furosemide—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000139	0.00296	CcSEcCtD
Furosemide—Drowsiness—Methotrexate—esophageal cancer	0.000139	0.00295	CcSEcCtD
Furosemide—Pain—Cisplatin—esophageal cancer	0.000138	0.00293	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000137	0.00293	CcSEcCtD
Furosemide—Vision blurred—Capecitabine—esophageal cancer	0.000137	0.00292	CcSEcCtD
Furosemide—Renal failure—Methotrexate—esophageal cancer	0.000136	0.0029	CcSEcCtD
Furosemide—Anaemia—Capecitabine—esophageal cancer	0.000134	0.00286	CcSEcCtD
Furosemide—Sweating—Methotrexate—esophageal cancer	0.000133	0.00283	CcSEcCtD
Furosemide—Feeling abnormal—Cisplatin—esophageal cancer	0.000133	0.00283	CcSEcCtD
Furosemide—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000131	0.00279	CcSEcCtD
Furosemide—Vertigo—Capecitabine—esophageal cancer	0.000131	0.00278	CcSEcCtD
Furosemide—Leukopenia—Capecitabine—esophageal cancer	0.00013	0.00277	CcSEcCtD
Furosemide—Agranulocytosis—Methotrexate—esophageal cancer	0.000129	0.00275	CcSEcCtD
Furosemide—Body temperature increased—Cisplatin—esophageal cancer	0.000127	0.00271	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000123	0.00262	CcSEcCtD
Furosemide—Urinary tract disorder—Methotrexate—esophageal cancer	0.000123	0.00262	CcSEcCtD
Furosemide—Urethral disorder—Methotrexate—esophageal cancer	0.000122	0.0026	CcSEcCtD
Furosemide—Dry mouth—Capecitabine—esophageal cancer	0.000121	0.00258	CcSEcCtD
Furosemide—Visual impairment—Methotrexate—esophageal cancer	0.00012	0.00255	CcSEcCtD
Furosemide—Confusional state—Capecitabine—esophageal cancer	0.00012	0.00255	CcSEcCtD
Furosemide—Hypersensitivity—Cisplatin—esophageal cancer	0.000119	0.00253	CcSEcCtD
Furosemide—Erythema multiforme—Methotrexate—esophageal cancer	0.000118	0.00251	CcSEcCtD
Furosemide—Shock—Capecitabine—esophageal cancer	0.000117	0.00249	CcSEcCtD
Furosemide—Nervous system disorder—Capecitabine—esophageal cancer	0.000116	0.00248	CcSEcCtD
Furosemide—Eye disorder—Methotrexate—esophageal cancer	0.000116	0.00248	CcSEcCtD
Furosemide—Thrombocytopenia—Capecitabine—esophageal cancer	0.000116	0.00248	CcSEcCtD
Furosemide—Tinnitus—Methotrexate—esophageal cancer	0.000116	0.00247	CcSEcCtD
Furosemide—Asthenia—Cisplatin—esophageal cancer	0.000116	0.00246	CcSEcCtD
Furosemide—Skin disorder—Capecitabine—esophageal cancer	0.000115	0.00246	CcSEcCtD
Furosemide—Hyperhidrosis—Capecitabine—esophageal cancer	0.000115	0.00244	CcSEcCtD
Furosemide—Anorexia—Capecitabine—esophageal cancer	0.000113	0.00241	CcSEcCtD
Furosemide—Angiopathy—Methotrexate—esophageal cancer	0.000113	0.0024	CcSEcCtD
Furosemide—Immune system disorder—Methotrexate—esophageal cancer	0.000112	0.00239	CcSEcCtD
Furosemide—Hypotension—Capecitabine—esophageal cancer	0.000111	0.00236	CcSEcCtD
Furosemide—Diarrhoea—Cisplatin—esophageal cancer	0.00011	0.00235	CcSEcCtD
Furosemide—Malnutrition—Methotrexate—esophageal cancer	0.000108	0.00231	CcSEcCtD
Furosemide—Erythema—Methotrexate—esophageal cancer	0.000108	0.00231	CcSEcCtD
Furosemide—Paraesthesia—Capecitabine—esophageal cancer	0.000107	0.00227	CcSEcCtD
Furosemide—Dysgeusia—Methotrexate—esophageal cancer	0.000106	0.00226	CcSEcCtD
Furosemide—Decreased appetite—Capecitabine—esophageal cancer	0.000103	0.0022	CcSEcCtD
Furosemide—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000102	0.00218	CcSEcCtD
Furosemide—Vomiting—Cisplatin—esophageal cancer	0.000102	0.00218	CcSEcCtD
Furosemide—Fatigue—Capecitabine—esophageal cancer	0.000102	0.00218	CcSEcCtD
Furosemide—Vision blurred—Methotrexate—esophageal cancer	0.000102	0.00217	CcSEcCtD
Furosemide—Rash—Cisplatin—esophageal cancer	0.000102	0.00216	CcSEcCtD
Furosemide—Pain—Capecitabine—esophageal cancer	0.000102	0.00216	CcSEcCtD
Furosemide—Constipation—Capecitabine—esophageal cancer	0.000102	0.00216	CcSEcCtD
Furosemide—Dermatitis—Cisplatin—esophageal cancer	0.000101	0.00216	CcSEcCtD
Furosemide—Anaemia—Methotrexate—esophageal cancer	0.0001	0.00213	CcSEcCtD
Furosemide—Feeling abnormal—Capecitabine—esophageal cancer	9.78e-05	0.00208	CcSEcCtD
Furosemide—Vertigo—Methotrexate—esophageal cancer	9.73e-05	0.00207	CcSEcCtD
Furosemide—Gastrointestinal pain—Capecitabine—esophageal cancer	9.71e-05	0.00207	CcSEcCtD
Furosemide—Leukopenia—Methotrexate—esophageal cancer	9.69e-05	0.00206	CcSEcCtD
Furosemide—Nausea—Cisplatin—esophageal cancer	9.57e-05	0.00204	CcSEcCtD
Furosemide—Urticaria—Capecitabine—esophageal cancer	9.43e-05	0.00201	CcSEcCtD
Furosemide—Abdominal pain—Capecitabine—esophageal cancer	9.38e-05	0.002	CcSEcCtD
Furosemide—Body temperature increased—Capecitabine—esophageal cancer	9.38e-05	0.002	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	9.15e-05	0.00195	CcSEcCtD
Furosemide—Confusional state—Methotrexate—esophageal cancer	8.91e-05	0.0019	CcSEcCtD
Furosemide—Anaphylactic shock—Methotrexate—esophageal cancer	8.84e-05	0.00188	CcSEcCtD
Furosemide—Hypersensitivity—Capecitabine—esophageal cancer	8.75e-05	0.00186	CcSEcCtD
Furosemide—Nervous system disorder—Methotrexate—esophageal cancer	8.67e-05	0.00185	CcSEcCtD
Furosemide—Thrombocytopenia—Methotrexate—esophageal cancer	8.65e-05	0.00184	CcSEcCtD
Furosemide—Skin disorder—Methotrexate—esophageal cancer	8.58e-05	0.00183	CcSEcCtD
Furosemide—Hyperhidrosis—Methotrexate—esophageal cancer	8.54e-05	0.00182	CcSEcCtD
Furosemide—Asthenia—Capecitabine—esophageal cancer	8.52e-05	0.00181	CcSEcCtD
Furosemide—Anorexia—Methotrexate—esophageal cancer	8.42e-05	0.00179	CcSEcCtD
Furosemide—Pruritus—Capecitabine—esophageal cancer	8.4e-05	0.00179	CcSEcCtD
Furosemide—Hypotension—Methotrexate—esophageal cancer	8.26e-05	0.00176	CcSEcCtD
Furosemide—Diarrhoea—Capecitabine—esophageal cancer	8.12e-05	0.00173	CcSEcCtD
Furosemide—Paraesthesia—Methotrexate—esophageal cancer	7.94e-05	0.00169	CcSEcCtD
Furosemide—Somnolence—Methotrexate—esophageal cancer	7.86e-05	0.00167	CcSEcCtD
Furosemide—Dizziness—Capecitabine—esophageal cancer	7.85e-05	0.00167	CcSEcCtD
Furosemide—Decreased appetite—Methotrexate—esophageal cancer	7.68e-05	0.00164	CcSEcCtD
Furosemide—Gastrointestinal disorder—Methotrexate—esophageal cancer	7.63e-05	0.00163	CcSEcCtD
Furosemide—Fatigue—Methotrexate—esophageal cancer	7.62e-05	0.00162	CcSEcCtD
Furosemide—Pain—Methotrexate—esophageal cancer	7.56e-05	0.00161	CcSEcCtD
Furosemide—Vomiting—Capecitabine—esophageal cancer	7.55e-05	0.00161	CcSEcCtD
Furosemide—Rash—Capecitabine—esophageal cancer	7.48e-05	0.00159	CcSEcCtD
Furosemide—Dermatitis—Capecitabine—esophageal cancer	7.48e-05	0.00159	CcSEcCtD
Furosemide—Headache—Capecitabine—esophageal cancer	7.44e-05	0.00158	CcSEcCtD
Furosemide—Feeling abnormal—Methotrexate—esophageal cancer	7.28e-05	0.00155	CcSEcCtD
Furosemide—Gastrointestinal pain—Methotrexate—esophageal cancer	7.23e-05	0.00154	CcSEcCtD
Furosemide—Nausea—Capecitabine—esophageal cancer	7.05e-05	0.0015	CcSEcCtD
Furosemide—Urticaria—Methotrexate—esophageal cancer	7.02e-05	0.0015	CcSEcCtD
Furosemide—Abdominal pain—Methotrexate—esophageal cancer	6.99e-05	0.00149	CcSEcCtD
Furosemide—Body temperature increased—Methotrexate—esophageal cancer	6.99e-05	0.00149	CcSEcCtD
Furosemide—Hypersensitivity—Methotrexate—esophageal cancer	6.51e-05	0.00139	CcSEcCtD
Furosemide—Asthenia—Methotrexate—esophageal cancer	6.34e-05	0.00135	CcSEcCtD
Furosemide—Pruritus—Methotrexate—esophageal cancer	6.25e-05	0.00133	CcSEcCtD
Furosemide—Diarrhoea—Methotrexate—esophageal cancer	6.05e-05	0.00129	CcSEcCtD
Furosemide—Dizziness—Methotrexate—esophageal cancer	5.84e-05	0.00124	CcSEcCtD
Furosemide—Vomiting—Methotrexate—esophageal cancer	5.62e-05	0.0012	CcSEcCtD
Furosemide—Rash—Methotrexate—esophageal cancer	5.57e-05	0.00119	CcSEcCtD
Furosemide—Dermatitis—Methotrexate—esophageal cancer	5.57e-05	0.00119	CcSEcCtD
Furosemide—Headache—Methotrexate—esophageal cancer	5.54e-05	0.00118	CcSEcCtD
Furosemide—Nausea—Methotrexate—esophageal cancer	5.25e-05	0.00112	CcSEcCtD
Furosemide—ALB—Hemostasis—ATP1B2—esophageal cancer	2.69e-05	0.000286	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—GNG7—esophageal cancer	2.68e-05	0.000284	CbGpPWpGaD
Furosemide—CA12—Metabolism—PSME2—esophageal cancer	2.67e-05	0.000283	CbGpPWpGaD
Furosemide—CA12—Metabolism—PSME1—esophageal cancer	2.67e-05	0.000283	CbGpPWpGaD
Furosemide—PGD—Disease—TGFBR2—esophageal cancer	2.67e-05	0.000283	CbGpPWpGaD
Furosemide—CA5A—Metabolism—CYP1B1—esophageal cancer	2.66e-05	0.000282	CbGpPWpGaD
Furosemide—CA6—Metabolism—CYP1B1—esophageal cancer	2.66e-05	0.000282	CbGpPWpGaD
Furosemide—CA9—Metabolism—TYMP—esophageal cancer	2.65e-05	0.000282	CbGpPWpGaD
Furosemide—CA2—Metabolism—GAPDH—esophageal cancer	2.63e-05	0.000279	CbGpPWpGaD
Furosemide—CA1—Metabolism—ALDOB—esophageal cancer	2.62e-05	0.000278	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	2.61e-05	0.000277	CbGpPWpGaD
Furosemide—CA2—Metabolism—CRABP1—esophageal cancer	2.61e-05	0.000276	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—GNG7—esophageal cancer	2.59e-05	0.000275	CbGpPWpGaD
Furosemide—CA4—Metabolism—GNG7—esophageal cancer	2.58e-05	0.000274	CbGpPWpGaD
Furosemide—CA9—Metabolism—CYP26A1—esophageal cancer	2.58e-05	0.000274	CbGpPWpGaD
Furosemide—PGD—Metabolism—CYP1B1—esophageal cancer	2.57e-05	0.000272	CbGpPWpGaD
Furosemide—CA14—Metabolism—CYP19A1—esophageal cancer	2.57e-05	0.000272	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—HMOX1—esophageal cancer	2.56e-05	0.000272	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—HSPA5—esophageal cancer	2.54e-05	0.00027	CbGpPWpGaD
Furosemide—PGD—Disease—SMAD4—esophageal cancer	2.52e-05	0.000268	CbGpPWpGaD
Furosemide—CA1—Metabolism—GAPDH—esophageal cancer	2.52e-05	0.000267	CbGpPWpGaD
Furosemide—CA9—Metabolism—ALOX15—esophageal cancer	2.52e-05	0.000267	CbGpPWpGaD
Furosemide—CA5A—Metabolism—CYP19A1—esophageal cancer	2.5e-05	0.000266	CbGpPWpGaD
Furosemide—CA6—Metabolism—CYP19A1—esophageal cancer	2.5e-05	0.000266	CbGpPWpGaD
Furosemide—CA1—Metabolism—CRABP1—esophageal cancer	2.5e-05	0.000265	CbGpPWpGaD
Furosemide—CA5B—Metabolism—CYP1B1—esophageal cancer	2.48e-05	0.000264	CbGpPWpGaD
Furosemide—CA7—Metabolism—CYP1B1—esophageal cancer	2.48e-05	0.000264	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	2.48e-05	0.000263	CbGpPWpGaD
Furosemide—CA2—Metabolism—GNG7—esophageal cancer	2.48e-05	0.000263	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—ABCB1—esophageal cancer	2.46e-05	0.000261	CbGpPWpGaD
Furosemide—ALB—Hemostasis—DOCK2—esophageal cancer	2.44e-05	0.000259	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—CDKN1A—esophageal cancer	2.43e-05	0.000257	CbGpPWpGaD
Furosemide—CA4—Metabolism—ALDH2—esophageal cancer	2.42e-05	0.000257	CbGpPWpGaD
Furosemide—PGD—Metabolism—CYP19A1—esophageal cancer	2.41e-05	0.000256	CbGpPWpGaD
Furosemide—CA9—Metabolism—GSTO1—esophageal cancer	2.4e-05	0.000255	CbGpPWpGaD
Furosemide—CA9—Metabolism—TPI1—esophageal cancer	2.4e-05	0.000255	CbGpPWpGaD
Furosemide—CA1—Metabolism—GNG7—esophageal cancer	2.38e-05	0.000252	CbGpPWpGaD
Furosemide—CA14—Metabolism—HMOX1—esophageal cancer	2.34e-05	0.000249	CbGpPWpGaD
Furosemide—CA7—Metabolism—CYP19A1—esophageal cancer	2.34e-05	0.000248	CbGpPWpGaD
Furosemide—CA5B—Metabolism—CYP19A1—esophageal cancer	2.34e-05	0.000248	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	2.33e-05	0.000248	CbGpPWpGaD
Furosemide—CA2—Metabolism—ALDH2—esophageal cancer	2.32e-05	0.000246	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—EP300—esophageal cancer	2.31e-05	0.000245	CbGpPWpGaD
Furosemide—CA4—Metabolism—GSTT1—esophageal cancer	2.3e-05	0.000244	CbGpPWpGaD
Furosemide—CA12—Metabolism—CYP1B1—esophageal cancer	2.3e-05	0.000244	CbGpPWpGaD
Furosemide—CA9—Metabolism—ALDOB—esophageal cancer	2.3e-05	0.000244	CbGpPWpGaD
Furosemide—CA6—Metabolism—HMOX1—esophageal cancer	2.28e-05	0.000242	CbGpPWpGaD
Furosemide—CA5A—Metabolism—HMOX1—esophageal cancer	2.28e-05	0.000242	CbGpPWpGaD
Furosemide—CA4—Metabolism—CYP2A6—esophageal cancer	2.28e-05	0.000242	CbGpPWpGaD
Furosemide—CA14—Metabolism—ABCB1—esophageal cancer	2.25e-05	0.000239	CbGpPWpGaD
Furosemide—CA1—Metabolism—ALDH2—esophageal cancer	2.23e-05	0.000236	CbGpPWpGaD
Furosemide—CA9—Metabolism—GAPDH—esophageal cancer	2.22e-05	0.000235	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	2.21e-05	0.000235	CbGpPWpGaD
Furosemide—CA2—Metabolism—GSTT1—esophageal cancer	2.21e-05	0.000234	CbGpPWpGaD
Furosemide—PGD—Metabolism—HMOX1—esophageal cancer	2.2e-05	0.000234	CbGpPWpGaD
Furosemide—CA9—Metabolism—CRABP1—esophageal cancer	2.2e-05	0.000233	CbGpPWpGaD
Furosemide—CA5A—Metabolism—ABCB1—esophageal cancer	2.19e-05	0.000233	CbGpPWpGaD
Furosemide—CA6—Metabolism—ABCB1—esophageal cancer	2.19e-05	0.000233	CbGpPWpGaD
Furosemide—CA2—Metabolism—CYP2A6—esophageal cancer	2.18e-05	0.000232	CbGpPWpGaD
Furosemide—CA12—Metabolism—CYP19A1—esophageal cancer	2.16e-05	0.00023	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—HMOX1—esophageal cancer	2.16e-05	0.000229	CbGpPWpGaD
Furosemide—CA4—Metabolism—PTGS1—esophageal cancer	2.16e-05	0.000229	CbGpPWpGaD
Furosemide—CA4—Metabolism—ENO1—esophageal cancer	2.16e-05	0.000229	CbGpPWpGaD
Furosemide—CA5B—Metabolism—HMOX1—esophageal cancer	2.13e-05	0.000226	CbGpPWpGaD
Furosemide—CA7—Metabolism—HMOX1—esophageal cancer	2.13e-05	0.000226	CbGpPWpGaD
Furosemide—CA4—Metabolism—PSME2—esophageal cancer	2.13e-05	0.000226	CbGpPWpGaD
Furosemide—CA4—Metabolism—PSME1—esophageal cancer	2.13e-05	0.000226	CbGpPWpGaD
Furosemide—CA1—Metabolism—GSTT1—esophageal cancer	2.12e-05	0.000225	CbGpPWpGaD
Furosemide—PGD—Metabolism—ABCB1—esophageal cancer	2.11e-05	0.000224	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—AQP3—esophageal cancer	2.11e-05	0.000224	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PFN1—esophageal cancer	2.1e-05	0.000223	CbGpPWpGaD
Furosemide—CA1—Metabolism—CYP2A6—esophageal cancer	2.09e-05	0.000222	CbGpPWpGaD
Furosemide—CA9—Metabolism—GNG7—esophageal cancer	2.09e-05	0.000222	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—PTGS2—esophageal cancer	2.08e-05	0.000221	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—ABCB1—esophageal cancer	2.07e-05	0.00022	CbGpPWpGaD
Furosemide—CA2—Metabolism—ENO1—esophageal cancer	2.07e-05	0.00022	CbGpPWpGaD
Furosemide—CA2—Metabolism—PTGS1—esophageal cancer	2.07e-05	0.00022	CbGpPWpGaD
Furosemide—PGD—Disease—HIF1A—esophageal cancer	2.07e-05	0.000219	CbGpPWpGaD
Furosemide—CA5B—Metabolism—ABCB1—esophageal cancer	2.05e-05	0.000217	CbGpPWpGaD
Furosemide—CA7—Metabolism—ABCB1—esophageal cancer	2.05e-05	0.000217	CbGpPWpGaD
Furosemide—CA2—Metabolism—PSME1—esophageal cancer	2.04e-05	0.000216	CbGpPWpGaD
Furosemide—CA2—Metabolism—PSME2—esophageal cancer	2.04e-05	0.000216	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—ATP4A—esophageal cancer	2.02e-05	0.000215	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	2.02e-05	0.000215	CbGpPWpGaD
Furosemide—CA1—Metabolism—ENO1—esophageal cancer	1.98e-05	0.000211	CbGpPWpGaD
Furosemide—CA1—Metabolism—PTGS1—esophageal cancer	1.98e-05	0.000211	CbGpPWpGaD
Furosemide—CA12—Metabolism—HMOX1—esophageal cancer	1.97e-05	0.00021	CbGpPWpGaD
Furosemide—CA9—Metabolism—ALDH2—esophageal cancer	1.96e-05	0.000208	CbGpPWpGaD
Furosemide—CA1—Metabolism—PSME2—esophageal cancer	1.96e-05	0.000207	CbGpPWpGaD
Furosemide—CA1—Metabolism—PSME1—esophageal cancer	1.96e-05	0.000207	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.95e-05	0.000207	CbGpPWpGaD
Furosemide—CA12—Metabolism—ABCB1—esophageal cancer	1.9e-05	0.000201	CbGpPWpGaD
Furosemide—PGD—Disease—NOS2—esophageal cancer	1.88e-05	0.000199	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—ABCB1—esophageal cancer	1.87e-05	0.000199	CbGpPWpGaD
Furosemide—CA9—Metabolism—GSTT1—esophageal cancer	1.86e-05	0.000198	CbGpPWpGaD
Furosemide—PGD—Disease—NOTCH1—esophageal cancer	1.86e-05	0.000197	CbGpPWpGaD
Furosemide—CA9—Metabolism—CYP2A6—esophageal cancer	1.84e-05	0.000195	CbGpPWpGaD
Furosemide—CA4—Metabolism—CYP1B1—esophageal cancer	1.84e-05	0.000195	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	1.76e-05	0.000187	CbGpPWpGaD
Furosemide—CA2—Metabolism—CYP1B1—esophageal cancer	1.76e-05	0.000187	CbGpPWpGaD
Furosemide—CA9—Metabolism—ENO1—esophageal cancer	1.74e-05	0.000185	CbGpPWpGaD
Furosemide—CA9—Metabolism—PTGS1—esophageal cancer	1.74e-05	0.000185	CbGpPWpGaD
Furosemide—CA4—Metabolism—CYP19A1—esophageal cancer	1.73e-05	0.000183	CbGpPWpGaD
Furosemide—CA9—Metabolism—PSME1—esophageal cancer	1.72e-05	0.000182	CbGpPWpGaD
Furosemide—CA9—Metabolism—PSME2—esophageal cancer	1.72e-05	0.000182	CbGpPWpGaD
Furosemide—ALB—Hemostasis—CFL1—esophageal cancer	1.7e-05	0.000181	CbGpPWpGaD
Furosemide—PGD—Disease—CREBBP—esophageal cancer	1.69e-05	0.000179	CbGpPWpGaD
Furosemide—CA1—Metabolism—CYP1B1—esophageal cancer	1.69e-05	0.000179	CbGpPWpGaD
Furosemide—CA2—Metabolism—CYP19A1—esophageal cancer	1.65e-05	0.000176	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—TP53—esophageal cancer	1.65e-05	0.000175	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.64e-05	0.000174	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.63e-05	0.000173	CbGpPWpGaD
Furosemide—ALB—Hemostasis—GNG7—esophageal cancer	1.61e-05	0.00017	CbGpPWpGaD
Furosemide—CA1—Metabolism—CYP19A1—esophageal cancer	1.59e-05	0.000168	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.58e-05	0.000168	CbGpPWpGaD
Furosemide—CA4—Metabolism—HMOX1—esophageal cancer	1.57e-05	0.000167	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—ABCB1—esophageal cancer	1.56e-05	0.000166	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—TP53—esophageal cancer	1.56e-05	0.000166	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	1.54e-05	0.000163	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—ABCC2—esophageal cancer	1.53e-05	0.000163	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	1.52e-05	0.000161	CbGpPWpGaD
Furosemide—CA4—Metabolism—ABCB1—esophageal cancer	1.51e-05	0.00016	CbGpPWpGaD
Furosemide—PGD—Disease—NOS3—esophageal cancer	1.51e-05	0.00016	CbGpPWpGaD
Furosemide—CA2—Metabolism—HMOX1—esophageal cancer	1.51e-05	0.00016	CbGpPWpGaD
Furosemide—CA14—Metabolism—CREBBP—esophageal cancer	1.5e-05	0.000159	CbGpPWpGaD
Furosemide—CA9—Metabolism—CYP1B1—esophageal cancer	1.48e-05	0.000157	CbGpPWpGaD
Furosemide—CA5A—Metabolism—CREBBP—esophageal cancer	1.46e-05	0.000155	CbGpPWpGaD
Furosemide—CA6—Metabolism—CREBBP—esophageal cancer	1.46e-05	0.000155	CbGpPWpGaD
Furosemide—CA2—Metabolism—ABCB1—esophageal cancer	1.45e-05	0.000154	CbGpPWpGaD
Furosemide—CA1—Metabolism—HMOX1—esophageal cancer	1.45e-05	0.000154	CbGpPWpGaD
Furosemide—PGD—Metabolism—CREBBP—esophageal cancer	1.41e-05	0.00015	CbGpPWpGaD
Furosemide—PGD—Disease—ERBB2—esophageal cancer	1.41e-05	0.00015	CbGpPWpGaD
Furosemide—CA9—Metabolism—CYP19A1—esophageal cancer	1.39e-05	0.000148	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—GNG7—esophageal cancer	1.39e-05	0.000148	CbGpPWpGaD
Furosemide—CA1—Metabolism—ABCB1—esophageal cancer	1.39e-05	0.000147	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.39e-05	0.000147	CbGpPWpGaD
Furosemide—PGD—Disease—PTGS2—esophageal cancer	1.38e-05	0.000147	CbGpPWpGaD
Furosemide—CA5B—Metabolism—CREBBP—esophageal cancer	1.37e-05	0.000145	CbGpPWpGaD
Furosemide—CA7—Metabolism—CREBBP—esophageal cancer	1.37e-05	0.000145	CbGpPWpGaD
Furosemide—ALB—Metabolism—BLVRB—esophageal cancer	1.37e-05	0.000145	CbGpPWpGaD
Furosemide—ALB—Metabolism—SLC52A3—esophageal cancer	1.37e-05	0.000145	CbGpPWpGaD
Furosemide—CA14—Metabolism—NOS3—esophageal cancer	1.35e-05	0.000143	CbGpPWpGaD
Furosemide—CA6—Metabolism—NOS3—esophageal cancer	1.31e-05	0.000139	CbGpPWpGaD
Furosemide—CA5A—Metabolism—NOS3—esophageal cancer	1.31e-05	0.000139	CbGpPWpGaD
Furosemide—ALB—Hemostasis—HSPA5—esophageal cancer	1.31e-05	0.000139	CbGpPWpGaD
Furosemide—CA9—Metabolism—HMOX1—esophageal cancer	1.27e-05	0.000135	CbGpPWpGaD
Furosemide—CA12—Metabolism—CREBBP—esophageal cancer	1.27e-05	0.000134	CbGpPWpGaD
Furosemide—PGD—Metabolism—NOS3—esophageal cancer	1.27e-05	0.000134	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.25e-05	0.000133	CbGpPWpGaD
Furosemide—CA14—Metabolism—PTGS2—esophageal cancer	1.23e-05	0.000131	CbGpPWpGaD
Furosemide—CA5B—Metabolism—NOS3—esophageal cancer	1.22e-05	0.00013	CbGpPWpGaD
Furosemide—CA7—Metabolism—NOS3—esophageal cancer	1.22e-05	0.00013	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	1.22e-05	0.00013	CbGpPWpGaD
Furosemide—CA9—Metabolism—ABCB1—esophageal cancer	1.22e-05	0.00013	CbGpPWpGaD
Furosemide—PGD—Disease—CDKN1A—esophageal cancer	1.21e-05	0.000128	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PTGS2—esophageal cancer	1.2e-05	0.000127	CbGpPWpGaD
Furosemide—CA6—Metabolism—PTGS2—esophageal cancer	1.2e-05	0.000127	CbGpPWpGaD
Furosemide—ALB—Metabolism—SLC10A2—esophageal cancer	1.16e-05	0.000123	CbGpPWpGaD
Furosemide—ALB—Metabolism—CA1—esophageal cancer	1.16e-05	0.000123	CbGpPWpGaD
Furosemide—PGD—Metabolism—PTGS2—esophageal cancer	1.16e-05	0.000123	CbGpPWpGaD
Furosemide—PGD—Disease—EP300—esophageal cancer	1.15e-05	0.000122	CbGpPWpGaD
Furosemide—CA12—Metabolism—NOS3—esophageal cancer	1.13e-05	0.00012	CbGpPWpGaD
Furosemide—CA7—Metabolism—PTGS2—esophageal cancer	1.12e-05	0.000119	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PTGS2—esophageal cancer	1.12e-05	0.000119	CbGpPWpGaD
Furosemide—ALB—Metabolism—CA2—esophageal cancer	1.06e-05	0.000113	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.05e-05	0.000111	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.04e-05	0.00011	CbGpPWpGaD
Furosemide—CA12—Metabolism—PTGS2—esophageal cancer	1.04e-05	0.00011	CbGpPWpGaD
Furosemide—CA14—Metabolism—EP300—esophageal cancer	1.02e-05	0.000109	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.01e-05	0.000107	CbGpPWpGaD
Furosemide—CA4—Metabolism—CREBBP—esophageal cancer	1.01e-05	0.000107	CbGpPWpGaD
Furosemide—PGD—Disease—MYC—esophageal cancer	1e-05	0.000106	CbGpPWpGaD
Furosemide—CA6—Metabolism—EP300—esophageal cancer	9.98e-06	0.000106	CbGpPWpGaD
Furosemide—CA5A—Metabolism—EP300—esophageal cancer	9.98e-06	0.000106	CbGpPWpGaD
Furosemide—ALB—Metabolism—PLCE1—esophageal cancer	9.88e-06	0.000105	CbGpPWpGaD
Furosemide—ALB—Metabolism—ADH7—esophageal cancer	9.88e-06	0.000105	CbGpPWpGaD
Furosemide—PGD—Disease—EGFR—esophageal cancer	9.8e-06	0.000104	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	9.77e-06	0.000104	CbGpPWpGaD
Furosemide—ALB—Hemostasis—ABL1—esophageal cancer	9.7e-06	0.000103	CbGpPWpGaD
Furosemide—CA2—Metabolism—CREBBP—esophageal cancer	9.69e-06	0.000103	CbGpPWpGaD
Furosemide—PGD—Metabolism—EP300—esophageal cancer	9.63e-06	0.000102	CbGpPWpGaD
Furosemide—CA5B—Metabolism—EP300—esophageal cancer	9.31e-06	9.88e-05	CbGpPWpGaD
Furosemide—CA7—Metabolism—EP300—esophageal cancer	9.31e-06	9.88e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—CREBBP—esophageal cancer	9.29e-06	9.85e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—NOS3—esophageal cancer	9.05e-06	9.6e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—NOS3—esophageal cancer	8.67e-06	9.2e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ADH1B—esophageal cancer	8.66e-06	9.19e-05	CbGpPWpGaD
Furosemide—CA12—Metabolism—EP300—esophageal cancer	8.63e-06	9.16e-05	CbGpPWpGaD
Furosemide—PGD—Disease—PIK3CA—esophageal cancer	8.5e-06	9.02e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—HMOX1—esophageal cancer	8.47e-06	8.99e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—NOS3—esophageal cancer	8.31e-06	8.82e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—TYMP—esophageal cancer	8.28e-06	8.79e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—PTGS2—esophageal cancer	8.27e-06	8.78e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—CREBBP—esophageal cancer	8.16e-06	8.66e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—ABCB1—esophageal cancer	8.13e-06	8.63e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP26A1—esophageal cancer	8.05e-06	8.55e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—PTGS2—esophageal cancer	7.93e-06	8.42e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ALOX15—esophageal cancer	7.85e-06	8.33e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—PTGS2—esophageal cancer	7.6e-06	8.07e-05	CbGpPWpGaD
Furosemide—CA14—Metabolism—PIK3CA—esophageal cancer	7.57e-06	8.04e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GSTO1—esophageal cancer	7.49e-06	7.95e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—TPI1—esophageal cancer	7.49e-06	7.95e-05	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PIK3CA—esophageal cancer	7.38e-06	7.83e-05	CbGpPWpGaD
Furosemide—CA6—Metabolism—PIK3CA—esophageal cancer	7.38e-06	7.83e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—NOS3—esophageal cancer	7.31e-06	7.76e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ALDOB—esophageal cancer	7.18e-06	7.62e-05	CbGpPWpGaD
Furosemide—PGD—Metabolism—PIK3CA—esophageal cancer	7.12e-06	7.56e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—NOS2—esophageal cancer	6.99e-06	7.42e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GAPDH—esophageal cancer	6.91e-06	7.33e-05	CbGpPWpGaD
Furosemide—CA7—Metabolism—PIK3CA—esophageal cancer	6.89e-06	7.31e-05	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PIK3CA—esophageal cancer	6.89e-06	7.31e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—EP300—esophageal cancer	6.88e-06	7.3e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CRABP1—esophageal cancer	6.85e-06	7.27e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—PTGS2—esophageal cancer	6.69e-06	7.09e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—EP300—esophageal cancer	6.6e-06	7e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GNG7—esophageal cancer	6.51e-06	6.91e-05	CbGpPWpGaD
Furosemide—CA12—Metabolism—PIK3CA—esophageal cancer	6.38e-06	6.77e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—EP300—esophageal cancer	6.32e-06	6.71e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—CREBBP—esophageal cancer	6.28e-06	6.66e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	6.14e-06	6.51e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ALDH2—esophageal cancer	6.1e-06	6.48e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GSTT1—esophageal cancer	5.81e-06	6.16e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP2A6—esophageal cancer	5.74e-06	6.09e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	5.72e-06	6.07e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—NOS3—esophageal cancer	5.62e-06	5.97e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—EP300—esophageal cancer	5.56e-06	5.9e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ENO1—esophageal cancer	5.44e-06	5.77e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PTGS1—esophageal cancer	5.44e-06	5.77e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—CREBBP—esophageal cancer	5.44e-06	5.77e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PSME1—esophageal cancer	5.36e-06	5.69e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PSME2—esophageal cancer	5.36e-06	5.69e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—PIK3CA—esophageal cancer	5.09e-06	5.4e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—PIK3CA—esophageal cancer	4.88e-06	5.18e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	4.68e-06	4.97e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—PIK3CA—esophageal cancer	4.68e-06	4.96e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP1B1—esophageal cancer	4.63e-06	4.91e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP19A1—esophageal cancer	4.35e-06	4.61e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—EP300—esophageal cancer	4.28e-06	4.54e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—PIK3CA—esophageal cancer	4.11e-06	4.36e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—HMOX1—esophageal cancer	3.97e-06	4.21e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.89e-06	4.13e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ABCB1—esophageal cancer	3.81e-06	4.04e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PIK3CA—esophageal cancer	3.16e-06	3.36e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—TP53—esophageal cancer	3.06e-06	3.25e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.88e-06	3.06e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CREBBP—esophageal cancer	2.55e-06	2.7e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—NOS3—esophageal cancer	2.28e-06	2.42e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PTGS2—esophageal cancer	2.08e-06	2.21e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—EP300—esophageal cancer	1.73e-06	1.84e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PIK3CA—esophageal cancer	1.28e-06	1.36e-05	CbGpPWpGaD
